Cell injection aims to repair damaged livers in early trial
Disease control
ENROLLING_BY_INVITATION
This early-phase trial tests a single injection of HCL001 cells in 39 people with decompensated cirrhosis, a severe form of liver disease. The study aims to check safety and see if the treatment can improve liver function. Participants receive one of three dose levels, and resear…
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Huicun Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC